Skip to main content
. 2020 Sep 18;20:282. doi: 10.1186/s12906-020-03066-4

Fig. 5.

Fig. 5

GO terms annotation (a) and KEGG pathway enrichment (b) of the targets (K ≥ 40) in the drug-target network of DSS